Eikon Therapeutics, Inc., operates as a clinical biopharmaceutical company in the United States. It develops medicines to address serious unmet medical needs. Its products include EIK1001, a systemically administered TLR 7/8 dual-agonist de...
Q1 2026
Mar 31, 2026
FY 2025
Mar 30, 2026
Q4 2025
Q1 2025
Mar 31, 2025
FY 2024
Dec 31, 2024